移动应用设计与评估其对干眼症患者临床结局影响:随机对照试验研究方案
本方案拟开发一款移动自我护理应用,并通过双臂盲法随机对照试验评估其对干眼症患者客观临床检测结果与主观症状的效果。原计划样本量104例,因COVID-19等不可预见挑战,实际随机化181例(干预组91例、对照组90例),42.5%脱落率后104例完成者。主要结局为泪膜破裂时间,次要结局为波斯版眼表疾病指数问卷,于基线后6周和12周评估。
要点
- 研究评估移动自我护理应用对干眼症患者泪膜破裂时间和眼表疾病指数问卷的影响。
- 实际随机化181例,脱落率42.5%,最终104例完成者。
- 干预组在常规医疗护理基础上使用移动应用12周。
核心结论
- 预期通过移动应用在临床访视期间提供定制化训练可促进病情改善、降低疾病严重程度并加强医患关系。
研究设计与样本
- 第一阶段使用Flask技术Python框架与SQLite数据库后端、Dart的Flutter框架前端开发移动自我护理应用。
- 第二阶段为双臂盲法随机对照试验,原计划样本量104例干眼症患者,通过在线随机数生成器分组。
- 因COVID-19等不可预见挑战,实际随机化181例患者(干预组91例、对照组90例),42.5%脱落率后104例完成者。
- 两组均接受常规医疗护理,干预组额外使用移动应用12周。
主要发现
- 主要结局为泪膜破裂时间临床检测,次要结局为经验证的波斯版眼表疾病指数问卷。
- 结局指标于基线后6周和12周评估。
临床怎么用
- 在临床访视期间通过移动应用提供定制化训练,可能促进干眼症病情改善并加强医患关系。
- 考虑到传统自我护理方法缺乏财政资源及移动健康技术发展,此类系统有望被干眼症患者接受。
局限性
- COVID-19干扰等不可预见挑战导致实际随机化样本量与原计划不符。
- 42.5%的脱落率导致最终完成者仅104例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dry eye is a common ocular surface disorder resulting from tear deficiency or excess tear evaporation. This protocol will be implemented for a study designed to determine the effectiveness of a mobile self-care application on objective clinical test results and subjective symptoms in patients with dry eye disease. METHODS: The first stage will include the development of a mobile self-care application using the Python framework of Flask technology and SQLite database in the backend, and the Flutter framework of Dart for the bot technology in the front end. The second stage will be conducted using a two-arm blinded randomized clinical trial. The sample size calculation initially targeted 104 patients with dry eye disease, intended for division into intervention and control groups via an online random number generator. However, unforeseen challenges, including COVID-19 disruptions, led to randomization of 181 patients (91 intervention, 90 control).This resulted in 104 completers after a 42.5% dropout rate. Patients in both groups will receive usual medical care, but those in the intervention group will also use a mobile-based application for a period of 12 weeks. Study outcomes including the Tear Break-Up Time clinical test as the primary outcome, and the validated Persian version of the Ocular Surface Disease Index questionnaire as a secondary outcome measure in patients with dry eye disease, will be assessed at 6- and 12-weeks post-baseline. DISCUSSION: It is expected that delivering customized training via a mobile application during clinical visits would promote improvement and reduction of disease severity, as well as strengthen the physician-patient relationship. This study was developed by an interdisciplinary research team in accordance with current dry eye disease guidelines and taking into account the medical history and classification of dry eye disease. Considering the lack of financial resources for traditional self-care methods and the development of technologies based on mobile health, it seems that one can hope for the acceptance of such systems in the patients with dry eyes. TRIAL REGISTRATION: This protocol is registered in the Iranian registration of clinical trial (IRCT) with the code IRCT20200721048162N1. Registered 31 August 2020, URL: https://irct.behdasht.gov.ir/trial/49779 .
引用
- Khodabandeh ME, Farrahi R, Sargolzaei M, et al. Design of a mobile application and evaluation of its effects on clinical outcomes in patients with dry eye disease: a study protocol for a randomized controlled trial. Trials. 2026. PMID: 42298714. doi:10.1186/s13063-025-09189-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。